BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 28068967)

  • 21. Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.
    Chen C; Shenoy AK; Padia R; Fang D; Jing Q; Yang P; Su SB; Huang S
    J Exp Clin Cancer Res; 2018 Oct; 37(1):243. PubMed ID: 30285892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility.
    Wang W; Liu Y; Liao K
    BMC Cell Biol; 2011 Nov; 12():49. PubMed ID: 22078467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
    Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
    J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MeHg affects the activation of FAK, Src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells.
    Hernández AJA; Reyes VL; Albores-García D; Gómez R; Calderón-Aranda ES
    Toxicology; 2018 Feb; 394():35-44. PubMed ID: 29197552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.
    Kishi T; Mayanagi T; Iwabuchi S; Akasaka T; Sobue K
    Oncotarget; 2016 Nov; 7(44):72113-72130. PubMed ID: 27708220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway.
    Liu W; Liang Y; Chan Q; Jiang L; Dong J
    Oncol Rep; 2019 Mar; 41(3):1911-1917. PubMed ID: 30628679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.
    Macha MA; Rachagani S; Gupta S; Pai P; Ponnusamy MP; Batra SK; Jain M
    Cancer Lett; 2013 Dec; 341(2):166-77. PubMed ID: 23920124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
    Chen H; Suo K; Cheng Y; Zheng B; Xu L
    Gynecol Endocrinol; 2013 Jan; 29(1):20-4. PubMed ID: 22817694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
    Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
    Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel synthetic ether lipid inositol-C2-PAF inhibits phosphorylation of the tyrosine kinases Src and FAK independent of integrin activation in transformed skin cells.
    Semini G; Hildmann A; Reissig HU; Reutter W; Danker K
    Biochem Pharmacol; 2011 Apr; 81(8):985-95. PubMed ID: 21320472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro.
    Xu XP; He HL; Hu SL; Han JB; Huang LL; Xu JY; Xie JF; Liu AR; Yang Y; Qiu HB
    Stem Cell Res Ther; 2017 Jul; 8(1):164. PubMed ID: 28697804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
    Hingorani P; Zhang W; Gorlick R; Kolb EA
    Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
    Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enterolactone Induces G
    Chikara S; Lindsey K; Dhillon H; Mamidi S; Kittilson J; Christofidou-Solomidou M; Reindl KM
    Nutr Cancer; 2017; 69(4):652-662. PubMed ID: 28323486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonorchis sinensis excretory-secretory products promote the migration and invasion of cholangiocarcinoma cells by activating the integrin β4-FAK/Src signaling pathway.
    Pak JH; Bashir Q; Kim IK; Hong SJ; Maeng S; Bahk YY; Kim TS
    Mol Biochem Parasitol; 2017 Jun; 214():1-9. PubMed ID: 28286026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
    Slack JK; Adams RB; Rovin JD; Bissonette EA; Stoker CE; Parsons JT
    Oncogene; 2001 Mar; 20(10):1152-63. PubMed ID: 11313859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.
    Shen J; Xu L; Owonikoko TK; Sun SY; Khuri FR; Curran WJ; Deng X
    Cancer Lett; 2012 May; 318(1):106-13. PubMed ID: 22178655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal adhesion kinase and Src mediate microvascular hyperpermeability caused by fibrinogen- γC- terminal fragments.
    Guo X; Eitnier RA; Beard RS; Meegan JE; Yang X; Aponte AM; Wang F; Nelson PR; Wu MH
    PLoS One; 2020; 15(4):e0231739. PubMed ID: 32352989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway.
    Zhang H; Zhang SH; He HW; Zhang CX; Yu DK; Shao RG
    Cancer Gene Ther; 2013 Nov; 20(11):622-9. PubMed ID: 24157923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.